Evidence map›Paper›PMID 26500347›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Costimulation of IL-2 Production through CD28 Is Dependent on the Size of Its Ligand.

Hong-Sheng Lim, Shaun-Paul Cordoba, Omer Dushek, Jesse Goyette, Alison Taylor, Christopher E Rudd, P Anton van der Merwe

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Theranostics · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Molecular biology and immunology of gastric cancer peritoneal metastasis.Translational gastroenterology and hepatology · 2020
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hong-Sheng LimSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom;
Shaun-Paul CordobaUniversity College London Cancer Institute, University College London, London WC1E 6DD, United Kingdom; and.ORCID http://orcid.org/0000-0002-6911-6525
Omer DushekSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom;
Jesse GoyetteSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom;
Alison TaylorDepartment of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom.
Christopher E RuddDepartment of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom.
P Anton van der MerweSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom; anton.vandermerwe@path.ox.ac.uk.
University of Oxford · GBUniversity of Cambridge · GBCRUK Lung Cancer Centre of Excellence · GB

Funding

Medical Research Council G19/31Medical Research Council G9722488Wellcome Trust 098363Wellcome Trust 101799Wellcome Trust 101799/Z/13/Z
6 · The paper itself

Abstract

Optimal T cell activation typically requires engagement of both the TCR and costimulatory receptors, such as CD28. Engagement of CD28 leads to tyrosine phosphorylation of its cytoplasmic region and recruitment of cytoplasmic signaling proteins. Although the exact mechanism of CD28 signal transduction is unknown, CD28 triggering has similarities to the TCR, which was proposed to use the kinetic-segregation (KS) mechanism. The KS model postulates that, when small receptors engage their ligands within areas of close (∼15 nm) contact in the T cell/APC interface, this facilitates phosphorylation by segregating the engaged receptor/ligand complex from receptor protein tyrosine phosphatases with large ectodomains, such as CD45. To test this hypothesis, we examined the effect of elongating the extracellular region of the CD28 ligand, CD80, on its ability to costimulate IL-2 production by primary T cells. CD80 elongation reduced its costimulatory effect without abrogating CD28 binding. Confocal microscopy revealed that elongated CD80 molecules were less well segregated from CD45 at the T cell/APC interface. T cells expressing CD28 harboring a key tyrosine-170 mutation were less sensitive to CD80 elongation. In summary, the effectiveness of CD28 costimulation is inversely proportional to the dimensions of the CD28-CD80 complex. Small CD28-CD80 complex dimensions are required for optimal costimulation by segregation from large inhibitory tyrosine phosphatases. These results demonstrate the importance of ligand dimensions for optimal costimulation of IL-2 production by T cells and suggest that the KS mechanism contributes to CD28 signaling.

Indexed as

AnimalsB7-1 AntigenCD28 AntigensCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell LineCHO CellsCricetinaeCricetulusInterleukin-2Leukocyte Common AntigensLymphocyte ActivationMiceMice, Inbred C57BLMice, TransgenicMultiprotein ComplexesB7-1 AntigenCD28 AntigensInterleukin-2Leukocyte Common AntigensMultiprotein ComplexesReceptors, Antigen, T-Cell

Identifiers

PMID26500347
PMCPMC4654228
OpenAlexW1880148174

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.